Your browser doesn't support javascript.
loading
Rv0495c regulates redox homeostasis in Mycobacterium tuberculosis.
Pal, Rahul; Talwar, Sakshi; Pandey, Manitosh; Nain, Vaibhav Kumar; Sharma, Taruna; Tyagi, Shaifali; Barik, Vishawjeet; Chaudhary, Shweta; Gupta, Sonu Kumar; Kumar, Yashwant; Nanda, Ranjan; Singhal, Amit; Pandey, Amit Kumar.
Afiliação
  • Pal R; Mycobacterial Pathogenesis Laboratory, Centre for Tuberculosis Research, Translational Health Science and Technology Institute, Faridabad, Haryana, India.
  • Talwar S; Mycobacterial Pathogenesis Laboratory, Centre for Tuberculosis Research, Translational Health Science and Technology Institute, Faridabad, Haryana, India.
  • Pandey M; Mycobacterial Pathogenesis Laboratory, Centre for Tuberculosis Research, Translational Health Science and Technology Institute, Faridabad, Haryana, India.
  • Nain VK; Mycobacterial Pathogenesis Laboratory, Centre for Tuberculosis Research, Translational Health Science and Technology Institute, Faridabad, Haryana, India; Jawaharlal Nehru University, New Delhi, India.
  • Sharma T; Mycobacterial Pathogenesis Laboratory, Centre for Tuberculosis Research, Translational Health Science and Technology Institute, Faridabad, Haryana, India; Jawaharlal Nehru University, New Delhi, India.
  • Tyagi S; Mycobacterial Pathogenesis Laboratory, Centre for Tuberculosis Research, Translational Health Science and Technology Institute, Faridabad, Haryana, India; Jawaharlal Nehru University, New Delhi, India.
  • Barik V; Mycobacterial Pathogenesis Laboratory, Centre for Tuberculosis Research, Translational Health Science and Technology Institute, Faridabad, Haryana, India; Jawaharlal Nehru University, New Delhi, India.
  • Chaudhary S; Translational Health Group, International Centre for Genetic Engineering and Biotechnology, New Delhi, India.
  • Gupta SK; Non-communicable Disease Centre, Translational Health Science and Technology Institute, Faridabad, Haryana, India.
  • Kumar Y; Non-communicable Disease Centre, Translational Health Science and Technology Institute, Faridabad, Haryana, India.
  • Nanda R; Translational Health Group, International Centre for Genetic Engineering and Biotechnology, New Delhi, India.
  • Singhal A; Infectious Diseases Labs (ID Labs), Agency for Science Technology and Research (A*STAR), Singapore, 138648, Republic of Singapore; Singapore Immunology Network (SIgN), A*STAR, Singapore, 138648, Republic of Singapore.
  • Pandey AK; Mycobacterial Pathogenesis Laboratory, Centre for Tuberculosis Research, Translational Health Science and Technology Institute, Faridabad, Haryana, India. Electronic address: amitpandey@thsti.res.in.
Tuberculosis (Edinb) ; 145: 102477, 2024 03.
Article em En | MEDLINE | ID: mdl-38211498
ABSTRACT
Mycobacterium tuberculosis (Mtb) has evolved sophisticated surveillance mechanisms to neutralize the ROS-induces toxicity which otherwise would degrade a variety of biological molecules including proteins, nucleic acids and lipids. In the present study, we find that Mtb lacking the Rv0495c gene (ΔRv0495c) is presented with a highly oxidized cytosolic environment. The superoxide-induced lipid peroxidation resulted in altered colony morphology and loss of membrane integrity in ΔRv0495c. As a consequence, ΔRv0495c demonstrated enhanced susceptibility when exposed to various host-induced stress conditions. Further, as expected, we observed a mutant-specific increase in the abundance of transcripts that encode proteins involved in antioxidant defence. Surprisingly, despite showing a growth defect phenotype in macrophages, the absence of the Rv0495c enhanced the pathogenicity and augmented the ability of the Mtb to grow inside the host. Additionally, our study revealed that Rv0495c-mediated immunomodulation by the pathogen helps create a favorable niche for long-term survival of Mtb inside the host. In summary, the current study underscores the fact that the truce in the war between the host and the pathogen favours long-term disease persistence in tuberculosis. We believe targeting Rv0495c could potentially be explored as a strategy to potentiate the current anti-TB regimen.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Tuberculose / Mycobacterium tuberculosis Limite: Humans Idioma: En Revista: Tuberculosis (Edinb) Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Índia

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Tuberculose / Mycobacterium tuberculosis Limite: Humans Idioma: En Revista: Tuberculosis (Edinb) Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Índia